MAKS-s – multimodal psychosocial intervention for people with severe dementia in inpatient care: a cluster-randomized controlled trial
- Conditions
- Severe dementia (degenerative type, not solely vascular)Nervous System DiseasesDementia
- Registration Number
- ISRCTN15722923
- Lead Sponsor
- German National Association of the Statutory Health Insurance and Long-Term Care Insurance Funds (GKV-Spitzenverband)
- Brief Summary
2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33059610/ protocol (added 22/10/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36577973/ (added 29/12/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 145
1. Psychometric verification of severe dementia syndrome: Mini Mental State Examination (MMSE) Score between 0 and 9
2. Informed consent for study participation
1. Mild to moderate dementia respectively no cognitive impairment (MMSE > 9)
2. Cognitive decline due to diseases other than dementia (e.g. schizophrenia or Korsakoff)
3. Severe hearing impairment
4. Severe visual impairment
5. Permanently bedridden persons
6. History of severe major depression
7. History of more than one stroke
8. No verbal communication in German possible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Quality of life measured by QUALIDEM<br> 2. Behavioural and psychological symptoms of dementia measured by Neuropsychiatric Inventory – Nursing Home Version (NPI-NH)<br> Measured at t0 (baseline), t2 (2 months after baseline), t6 (6 months after baseline)<br><br> Updated 15/01/2020:<br> Measured at t0 (baseline), t2 (2 months after baseline), t6 (6 months after baseline), t12 (12 months after baseline)<br>
- Secondary Outcome Measures
Name Time Method